These recommendations are meant to guide empiric therapeutic decision making and are not meant to replace sound clinical decision making. Definitive therapy should be based on culture and susceptibility reports
Hooton et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infections in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. CID. 2010:50;625-663.
Gupta et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2019 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. CID. 2011;52:e103.
Nicolle et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. CID. 2019:68;e83-75.
Gomila et al. Risk factors and prognosis of complicated urinary tract infections caused by pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study. Infect Drg Resist. 2018;11:2571-2581.
Yahav et al. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. CID. 2019;69:1091-1098.